Chargement en cours...
Immunotherapy advances for glioblastoma
Survival for patients with glioblastoma, the most common high-grade primary CNS tumor, remains poor despite multiple therapeutic interventions including intensifying cytotoxic therapy, targeting dysregulated cell signaling pathways, and blocking angiogenesis. Exciting, durable clinical benefits have...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4201077/ https://ncbi.nlm.nih.gov/pubmed/25190673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou212 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|